Year | Study site | Drugs used | No enrolled | ACPR (%) 28Â days |
---|---|---|---|---|
2007 | Serbo | AL | 90 | 97.6 |
2007 | Wondo | AL | 103 | 96.9 |
2008 | Shele | AL | 98 | 98.9 |
2011 | Wondo | AL | 90 | 92.5 |
2011 | Shele | AL | 100 | 96.7 |
2010 | Pawe | AL | 106 | 99 |
2013 | Pawe | AL | 101 | 99 |
2010 | Selekleka | AL | 102 | 100 |
2010 | Halaba | AL | 89 | 98.7 |
2010 | Woreta | AL | 89 | 100 |
2013 | Woreta | AL | 79 | 100 |
2014 | Humera | AL | 92 | 98.8 |
2014 | Metema | AL | 91 | 98.8 |
2014 | Metehara | AL | 91 | 98.8 |
2014 | Werere | AL | 91 | 100 |
2017/18 | Pawe | AL | 89 | 97.8 |
2017/18 | A/minch | AL | 11 | 100 |
2017/18 | Pawe | DHA-PPQ | 59 | 100 |
2017/18 | A/minch | DHA-PPQ | 9 | 100 |
2020/21 | A/minch | AL | 88 | 98.6 |
2020/21 | S/robit | AL | 14 | 100 |
2021 | Metehara | AL | 80 | 98.7 |
2020/21 | Hamusit | DHA-PPQ | 90 | 98 |
2021 | Hamusit | PY-AS (Pyramax) | 90 | 97.7 |
2022/23 | A/minch | AL(singledose Pq) | 88 | 96.6 |
2022/23 | Hamusit | AL(singledose Pq) | 91 | 97.8 |
2022/23 | Metehara | AL(singledose Pq) | 88 | 97.8 |
2022/23 | Bahirdar | AL(singledose Pq) | 60 | 98.3 |